Collins Stewart Starts BioMimetic Therapeutics (BMTI) at Buy, Price Target Calls for 143% Upside

Go back to Collins Stewart Starts BioMimetic Therapeutics (BMTI) at Buy, Price Target Calls for 143% Upside
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) Delayed: 9.49 --0 (-0%)
Previous Close $9.49    52 Week High $9.56 
Open $9.49    52 Week Low $2.01 
Day High $9.49    P/E N/A 
Day Low $9.49    EPS $-0.97 
Volume 1,100       

MELA SCIENCES (NASDAQ: MELA) Delayed: 1.12 --0 (-0%)
Previous Close $1.12    52 Week High $4.05 
Open $0.17    52 Week Low $1.00 
Day High $1.12    P/E N/A 
Day Low $1.12    EPS $-0.70 
Volume 10,494       

Orexigen Therapeutics, Inc. (NASDAQ: OREX) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $4.75 
Open $0.04    52 Week Low $0.35 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-1.02 
Volume 74,385       

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) Delayed: 1.70 --0 (-0%)
Previous Close $1.70    52 Week High $3.83 
Open $0.20    52 Week Low $1.55 
Day High $1.70    P/E N/A 
Day Low $1.70    EPS $-1.54 
Volume 200